Panome Bio logo

Panome Bio

St. Louis, MO

Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems. We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic’s SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.

panomebio.com

Company Details

Founded

2022

Employees

Between 10 - 50 employees

Raised

$5,973,835

Headquarters Location

St. Louis, MO

Public

No

Acquired

No

CEO

Edward WeinsteinEdward Weinstein

Founders

Tom Cohen
Tom Cohen
Gary Patti
Gary Patti
Edward Weinstein
Edward Weinstein

Company Collections

These are collections Panome Bio is a part of. Click on the collection name to view similar companies.

Panome Bio's Industries